ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies von Ishizawa, Jo, Kojima, Kensuke, Chachad, Dhruv, Ruvolo, Peter, Ruvolo, Vivian, Jacamo, Rodrigo O, Borthakur, Gautam, Mu, Hong, Zeng, Zhihong, Tabe, Yoko, Allen, Joshua E, Wang, Zhiqiang, Ma, Wencai, Lee, Hans C, Orlowski, Robert, Sarbassov, Dos D, Lorenzi, Philip L, Huang, Xuelin, Neelapu, Sattva S, McDonnell, Timothy, Miranda, Roberto N, Wang, Michael, Kantarjian, Hagop, Konopleva, Marina, Davis, R Eric, Andreeff, Michael

Volltext

Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma von Zhuang, Junling, Shirazi, Fazal, Singh, Ram Kumar, Kuiatse, Isere, Wang, Hua, Lee, Hans C., Berkova, Zuzana, Berger, Allison, Hyer, Marc, Chattopadhyay, Nibedita, Syed, Sakeena, Shi, Judy Qiuju, Yu, Jie, Shinde, Vaishali, Tirrell, Stephen, Jones, Richard Julian, Wang, Zhiqiang, Davis, R. Eric, Orlowski, Robert Z.

Volltext

Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life von Terpos, Evangelos, Mikhael, Joseph, Hajek, Roman, Chari, Ajai, Zweegman, Sonja, Lee, Hans C., Mateos, María-Victoria, Larocca, Alessandra, Ramasamy, Karthik, Kaiser, Martin, Cook, Gordon, Weisel, Katja C., Costello, Caitlin L., Elliott, Jennifer, Palumbo, Antonio, Usmani, Saad Z.

Volltext

Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial von Szymura, Szymon J., Wang, Lin, Zhang, Tiantian, Cha, Soung-chul, Song, Joo, Dong, Zhenyuan, Anderson, Aaron, Oh, Elizabeth, Lee, Vincent, Wang, Zhe, Parshottam, Sapna, Rao, Sheetal, Olsem, Jasper B., Crumpton, Brandon N., Lee, Hans C., Manasanch, Elisabet E., Neelapu, Sattva, Kwak, Larry W., Thomas, Sheeba K.

Volltext

Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: a real-world observational study in the United States von Hultcrantz, Malin, Kleinman, David, Vij, Ravi, Escalante, Fernando, Delforge, Michel, Kotowsky, Nirali, Bitetti, Jacopo, Boytsov, Natalie, Camadoo-O'Byrne, Leena, Happ, Lindsey Powers, Germain, Guillaume, Urosevic, Ana, Mahendran, Malena, Duh, Mei Sheng, Laliberte, Francois, Cavo, Michele, Lee, Hans C

Volltext

Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression von Jones, Richard J, Iempridee, Tawin, Wang, Xiaobin, Lee, Hans C, Mertz, Janet E, Kenney, Shannon C, Lin, Heather C, Baladandayuthapani, Veerabhadran, Dawson, Christopher W, Shah, Jatin J, Weber, Donna M, Orlowski, Robert Z

Volltext

How I treat relapsed and/or refractory multiple myeloma von Lee, Hans C, Cerchione, Claudio

Volltext

Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the... von Davies, Faith, Rifkin, Robert, Costello, Caitlin, Morgan, Gareth, Usmani, Saad, Abonour, Rafat, Palumbo, Antonio, Romanus, Dorothy, Hajek, Roman, Terpos, Evangelos, Cherepanov, Dasha, Stull, Dawn Marie, Huang, Hui, Leleu, Xavier, Berdeja, Jesus, Lee, Hans C., Weisel, Katja, Thompson, Michael, Boccadoro, Mario, Zonder, Jeffrey, Cook, Gordon, Puig, Noemi, Vela-Ojeda, Jorge, Farrelly, Eileen, Raju, Aditya, Blazer, Marlo, Chari, Ajai

Volltext

Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma von Srour, Samer A, Milton, Denái R, Bashir, Qaiser, Nieto, Yago, Saini, Neeraj, Daher, May, Ramdial, Jeremy, Im, Jin, Hosing, Chitra, Delgado, Ruby, Manasanch, Elisabet, Lee, Hans C, Thomas, Sheeba, Kaufman, Greg, Patel, Krina, Popat, Uday, Weber, Donna, Orlowski, Robert, Shpall, Elizabeth, Champlin, Richard E, Qazilbash, Muzaffar H

Volltext

New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity von Elhammali, Adnan, Amini, Behrang, Ludmir, Ethan B, Gunther, Jillian R, Milgrom, Sarah A, Pinnix, Chelsea C, Andraos, Therese, Yoder, Alison, Weber, Donna, Orlowski, Robert, Manasanch, Elisabet, Patel, Krina, Strati, Paolo, Nair, Ranjit, Lee, Hans C, Thomas, Sheeba, Iyer, Swaminathan, Kaufmann, Gregory, Garg, Naveen, Dabaja, Bouthaina S

Volltext

The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma von Becnel, Melody R., Lee, Hans C.

Volltext

The role of bone‐modifying agents in myeloma bone disease von Lu, Huifang, Pundole, Xerxes, Lee, Hans C.

Volltext

Phase I/Ib study of carfilzomib and panobinostat with or without dexamethasone in patients with relapsed/refractory multiple myeloma von Manasanch, Elisabet E, Shah, Jatin J, Lee, Hans C, Weber, Donna M, Thomas, Sheeba K, Amini, Behrang, Olsem, Jasper, Crumpton, Brandon, Morphey, Ashley, Berkova, Zuzana, Feng, Lei, Orlowski, Robert Z

Volltext

The Imipridone ONC201 Induces Apoptosis and Overcomes Chemotherapy Resistance by Up-Regulation of Bim in Multiple Myeloma von Tu, Yong-sheng, He, Jin, Liu, Huan, Lee, Hans C., Wang, Hua, Ishizawa, Jo, Allen, Joshua E., Andreeff, Michael, Orlowski, Robert Z., Davis, Richard E., Yang, Jing

Volltext

Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry von Ailawadhi, Sikander, Lee, Hans C., Omel, James, Toomey, Kathleen, Hardin, James W., Gasparetto, Cristina J., Jagannath, Sundar, Rifkin, Robert M., Durie, Brian G. M., Narang, Mohit, Terebelo, Howard R., Joshi, Prashant, Jou, Ying-Ming, Mouro, Jorge, Yu, Edward, Abonour, Rafat

Volltext

Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes von Purushothaman, Anurag, Bandari, Shyam K, Chandrashekar, Darshan S, Jones, Richard J, Lee, Hans C, Weber, Donna M, Orlowski, Robert Z

Volltext

Optimal infused CD34+ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation von Pasvolsky, Oren, Marcoux, Curtis, Milton, Denái R., Pal, Babar, Tanner, Mark R., Bashir, Qaiser, Srour, Samer, Lee, Jaehyun, Saini, Neeraj, Lin, Paul, Ramdial, Jeremy, Nieto, Yago, Tang, Guilin, Aljawai, Yosra, Kebriaei, Partow, Becnel, Melody R., Lee, Hans C., Patel, Krina K., Thomas, Sheeba K., Orlowski, Robert Z., Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar H.

Volltext

Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation von Pasvolsky, Oren, Wang, Zhongya, Milton, Denái R., Tanner, Mark R., Bashir, Qaiser, Srour, Samer, Saini, Neeraj, Lin, Paul, Ramdial, Jeremy, Nieto, Yago, Tang, Guilin, Kebriaei, Partow, Aljawai, Yosra, Khan, Hina N., Lee, Hans C., Ye, Christine, Patel, Krina K., Thomas, Sheeba K., Orlowski, Robert Z., Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar H.

Volltext

Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience von Pasvolsky, Oren, Ghanem, Sassine, Milton, Denái R., Rauf, Mikael, Tanner, Mark R., Bashir, Qaiser, Srour, Samer, Saini, Neeraj, Lin, Paul, Ramdial, Jeremy, Nieto, Yago, Tang, Guilin, Aljawai, Yosra, Khan, Hina N., Kebriaei, Partow, Lee, Hans C., Patel, Krina K., Thomas, Sheeba K., Weber, Donna M., Orlowski, Robert Z., Shpall, Elizabeth J., Champlin, Richard E., Qazilbash, Muzaffar H.

Volltext

Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients von Pasvolsky, Oren, Milton, Denái R., Rauf, Mikael, Ghanem, Sassine, Masood, Adeel, Mohamedi, Ali H., Tanner, Mark R., Bashir, Qaiser, Srour, Samer, Saini, Neeraj, Lin, Paul, Ramdial, Jeremy, Nieto, Yago, Tang, Guilin, Lee, Hans C., Patel, Krina K., Kebriaei, Partow, Thomas, Sheeba K., Weber, Donna M., Orlowski, Robert Z., Rezvani, Katy, Champlin, Richard, Shpall, Elizabeth J., Lin, Pei, Qazilbash, Muzaffar H.

Volltext